Stay updated on Granix Disruption in Myeloma Transplant Clinical Trial
Sign up to get notified when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.

Latest updates to the Granix Disruption in Myeloma Transplant Clinical Trial page
- Check6 days agoChange DetectedThe page now includes related topics: Multiple myeloma and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoChange DetectedRevision: v3.4.2 added; a funding notice and several related topics (including 'Multiple myeloma' and 'MedlinePlus Genetics') were removed.SummaryDifference0.6%

- Check20 days agoChange DetectedA site-wide funding status notice was added, the page revision updated from v3.4.0 to v3.4.1, and related topics such as Multiple Myeloma and MedlinePlus Genetics were added.SummaryDifference0.6%

- Check28 days agoChange DetectedUI/content changes include adding a glossary display and new QC-related metadata labels such as 'Last Update Submitted that Met QC Criteria', along with the revision note 'Revision: v3.4.0'; at the same time, several terms and topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' were removed from related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check35 days agoChange DetectedRelated topics for Multiple Myeloma and MedlinePlus Genetics have been added to the page, offering quick background links for readers.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows an updated revision label (v3.3.4) replacing the previous (v3.3.3), with no changes to study details or eligibility criteria.SummaryDifference0.1%

Stay in the know with updates to Granix Disruption in Myeloma Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.